Farber, Alik ; Division of Vascular and Endovascular Surgery, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts, USA.
Menard, Matthew T; Division of Vascular and Endovascular Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Bonaca, Marc P; Division of Cardiovascular Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.
Bradbury, Andrew; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Conte, Michael S; Division of Vascular and Endovascular Surgery, University of California, SanFrancisco, California, USA.
Debus, E Sebastian ; Department for Vascular Medicine, University Heart & Vascular Center Hamburg, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Eldrup, Nikolaj; Department of Vascular Surgery, Rigshospitalet, Copenhagen University, Copenhagen, Denmark.
Goodney, Philip ; Heart and Vascular Center, Dartmouth Hitchcock Medical Center, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA.
Gupta, Prem C; Department of Vascular and Endovascular Surgery, Care Hospital, Banjara Hills, Hyderabad, India.
Hinchliffe, Robert J ; Department of Vascular Surgery, University of Bristol, Bristol, UK.
Houlind, Kim C ; Department of Vascular Surgery, Kolding Hospital, Kolding, Denmark. ; University of Southern Denmark, Kolding, Denmark.
Kolh, Philippe ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biochimie et physiologie générales, humaines et pathologiques
Kum, Steven Wei Cheong; Department of Surgery, Changi General Hospital, Singapore.
Nordanstig, Joakim ; Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.
Parikh, Sahil A; Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Patel, Manesh R; Division of Cardiology, Duke Clinical Research Institute, Duke University, Durham, North Carolina, USA.
Patrone, Lorenzo; West London Vascular and Interventional Centre, London North West University NHS Trust, London, UK.
Sillesen, Henrik ; Novo Nordisk Foundation, Hellerup, Denmark.
Strong, Michael B; Division of Vascular and Endovascular Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Varcoe, Ramon L; Department of Surgery, Prince of Wales Hospital and Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.
Vega de Ceniga, Melina; Department of Angiology and Vascular Surgery, Hospital Universitario de Galdako-Usansolo, Galdakao, Spain. ; University of the Basque Country (UPV/EHU), Leioa, Spain. ; Research Institute BioBizkaia, Barakaldo, Spain.
Venermo, Maarit A ; Department of Vascular Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Rosenfield, Kenneth; Section of Vascular Medicine and Intervention Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Fowkes FG, Aboyans V, Fowkes FJ, McDermott MM, Sampson UK, Criqui MH. Peripheral artery disease: epidemiology and global perspectives. Nat Rev Cardiol 2017;14:156–170
Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg 2019;69:3S–125S.e40
Nehler MR, Duval S, Diao L, Annex BH, Hiatt WR, Rogers K et al. Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population. J Vasc Surg 2014;60: 686–695.e2
Farber A. Chronic limb-threatening ischemia. N Engl J Med 2018; 379:171–180
Conte MS, Farber A. Revascularization for chronic limb-threatening ischaemia. Br J Surg 2015;102:1007–1009
Farber A, Menard MT, Conte MS, Kaufman JA, Powell RJ, Choudhry NK et al. Surgery or endovascular therapy for chronic limb-threatening ischemia. N Engl J Med 2022;387:2305–2316
Bradbury AW, Moakes CA, Popplewell M, Meecham L, Bate GR, Kelly L et al. A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial. Lancet 2023;401:1798–1809
Popplewell MA, Meecham L, Davies HOB, Kelly L, Ellis T, Bate GR et al. Bypass versus Angioplasty for Severe Ischaemia of the Leg (BASIL) prospective cohort study and the generalisability of the BASIL-2 randomised controlled trial. Eur J Vasc Endovasc Surg 2023; https://doi.org/10.1016/j.ejvs.2023.09.041 [Epub ahead of print]
Pymer S, Harwood AE, Long J, Chetter IC, Saratzis A, Coughlin P. Research priorities for patients with peripheral arterial disease: a James Lind Alliance Priority Setting Partnership. J Vasc Soc G B Irel 2022; https://doi.org/10.54522/jvsgbi.2022.011
Paulli S, Gunnarsson C, Kotlarz H, Martinsen BJ, Zhao R, Rizzo JA. Impact of a limb salvage program on the economic burden of amputation in the United States. Value Health 2016;19:A45
Fanari Z, Weintraub WS. Cost-effectiveness of medical, endovascular and surgical management of peripheral vascular disease. Cardiovasc Revasc Med 2015;16:421–425
Varcoe RL, DeRubertis BG, Kolluri R, Krishnan P, Metzger DC, Bonaca MP et al. Drug-eluting resorbable scaffold versus angioplasty for infrapopliteal artery disease. N Engl J Med 2023; https://doi.org/10.1056/NEJMoa2305637 [Epub ahead of print]
Bonaca MP, Creager MA. Pharmacological treatment and current management of peripheral artery disease. Circ Res 2015;116:1579–1598
Bonaca MP, Nault P, Giugliano RP, Keech AC, Pineda AL, Kanevsky E et al. Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk). Circulation 2018;137:338–350
Schwartz GG, Steg PG, Szarek M, Bittner VA, Diaz R, Goodman SG et al. Peripheral artery disease and venous thromboembolic events after acute coronary syndrome: role of lipoprotein(a) and modification by alirocumab: prespecified analysis of the ODYSSEY OUTCOMES randomized clinical trial. Circulation 2020;141:1608–1617
Hess CN, Cannon CP, Beckman JA, Goodney PP, Patel MR, Hiatt WR et al. Effectiveness of blood lipid management in patients with peripheral artery disease. J Am Coll Cardiol 2021;77:3016–3027
Verma S, Al-Omran M, Leiter LA, Mazer CD, Rasmussen S, Saevereid HA et al. Cardiovascular efficacy of liraglutide and semaglutide in individuals with diabetes and peripheral artery disease. Diabetes Obes Metab 2022;24:1288–1299
Dhatariya K, Bain SC, Buse JB, Simpson R, Tarnow L, Kaltoft MS et al. The impact of liraglutide on diabetes-related foot ulceration and associated complications in patients with type 2 diabetes at high risk for cardiovascular events: results from the LEADER trial. Diabetes Care 2018;41:2229–2235
Bonaca MP, Wiviott SD, Zelniker TA, Mosenzon O, Bhatt DL, Leiter LA et al. Dapagliflozin and cardiac, kidney, and limb outcomes in patients with and without peripheral artery disease in DECLARE-TIMI 58. Circulation 2020;142:734–747
Verma S, Dhingra NK, Bonaca MP, Butler J, Anker SD, Ferreira JP et al. Presence of peripheral artery disease is associated with increased risk of heart failure events: insights from EMPEROR-Pooled. Arterioscler Thromb Vasc Biol 2023;43:1334–1337
Matthews DR, Li Q, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G et al. Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS program. Diabetologia 2019;62:926–938
Perkovic V, Jardine MJ, Neal B, Bompoint S, Heerspink HJL, Charytan DM et al. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N Engl J Med 2019;380:2295–2306
Hiatt WR, Bonaca MP, Patel MR, Nehler MR, Debus ES, Anand SS et al. Rivaroxaban and aspirin in peripheral artery disease lower extremity revascularization: impact of concomitant clopidogrel on efficacy and safety. Circulation 2020;142:2219–2230
Peripheral Arterial Disease: Diagnosis and Management: [A] Evidence review for determining diagnosis and severity of PAD in people with diabetes. London: National Institute for Health and Care Excellence, 2018
Aboyans V, Ricco JB, Bartelink MEL, Björck M, Brodmann M, Cohnert T et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Endorsed by: the European Stroke Organization (ESO). The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J 2018;39:763–816
Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2017;135:e686–e725
Frank U, Nikol S, Belch J, Boc V, Brodmann M, Carpentier PH et al. ESVM guideline on peripheral arterial disease. Vasa 2019; 48(Suppl 102): 1–79
Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. Eur J Vasc Endovasc Surg 2019; 58(Suppl): S1–S109.e33
Hunt BD, Popplewell MA, Davies H, Meecham L, Jarrett H, Bate G et al. BAlloon versus Stenting in severe Ischaemia of the Leg-3 (BASIL-3): study protocol for a randomised controlled trial. Trials 2017;18:224
